Binhai Investment (02886) received increased investment from Tianjin Teda and Sinopec, furthering its natural gas and clean energy strategy.
[Major Events]
Binhai Investment (02886) received increased investment from Tianjin Teda and Sinopec, furthering its natural gas and clean energy strategy.
Jinxin Reproductive (01951) commenced trial operations at its new Shenzhen Zhongshan Maternity Hospital. The number of oocyte retrieval cycles in the first two months increased by 18% year-over-year, while in the United States, it grew by approximately 38% year-over-year.
CSPC Pharma (01093): Emicizumab Injection (SYS 6053) Receives Clinical Trial Approval in China
Hengrui Pharma (01276): SHR-A2102 for injection and SHR-8068 injection have received approval notices for clinical trials.
Hengrui Pharma (01276) announced that its subsidiary received clinical trial approval for the drug HRS-1780 tablets.
Hutchmed (00013) has initiated a global study of HMPL-A580, a PI3K/PIKK-EGFR ATTC candidate drug for the treatment of solid tumors.
Zhonghui Bio-B (02627): mRNA monkeypox vaccine receives FDA approval in the United States.
[Earnings Report Data]
Uni-President China (00220) released its annual results, reporting a shareholder attributable profit of 2.05 billion yuan, an increase of 10.88% year-over-year, with a final dividend of 0.4747 yuan per share.
Celadon Game (06633) has announced a profit alert, expecting its net profit for the fiscal year 2025 to increase by approximately 134% to 197% year-over-year.
Western Cement (02233) issued a profit alert, expecting shareholder attributable profits for the fiscal year 2025 to increase by approximately 33% to 43% year-over-year.
Chizheng Technology (09911) issued a profit alert, projecting shareholder attributable profits for 2025 to be approximately 900 million to 940 million yuan, representing a year-over-year growth of about 87.5% to 95.8%.
Zhou Hei Ya (01458) issued a profit alert, expecting its net profit for 2025 to be between RMB 150 million and RMB 165 million, representing a year-on-year increase of approximately 52.7% to 68.0%.
China Power International (02380) reported total consolidated electricity sales of 10.4595 million megawatt-hours in January, representing a year-on-year increase of 4.79%.
